Ginkgo Bioworks Holdings Inc. Class A (DNA)
NYSE: DNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 11.47 0.00%
DNA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $772.39M
- EPS (TTM)
- -$5.06
- Dividend yield
- None
- 52-week range
- 5.37 – 18.22
- Day range
- 10.82 – 11.95
- Volume / Avg
- 6.43M / 1.68M
- Beta
- —
- Shares outstanding
- 55.38M
- Next earnings
- Nov 5, 2026
52-week range
DNA stock today
Shares of Ginkgo Bioworks (DNA) finished lower on Oct 7 at $11.47, a drop of 7.57% or $0.94 per share, versus the S&P 500's 0.22% decline. Volume was 3.8x the average at 6.43M shares, a sign of unusually heavy trading. Shares are 37.0% below their 52-week high of $18.22 and 113.6% above the 52-week low of $5.37, in the middle of the past year's range.
Ginkgo Bioworks has posted a net loss over the last twelve months (EPS of -$5.06), so its P/E ratio is not meaningful. Ginkgo Bioworks's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Ginkgo Bioworks
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.58
DNA news
All DNA newsGinkgo Bioworks peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SANASana Biotechnology Inc. | 2.72 | -1.09% | $814.26M | vs DNA |
| CADLCandel Therapeutics Inc. | 9.82 | -0.51% | $751.41M | vs DNA |
| SLBTSL Science Holding Limited | 1.51 | -0.66% | $846.75M | vs DNA |
| ATTOAttovia Therapeutics Inc. | 16.42 | -6.17% | $749.59M | vs DNA |
| SLDBSolid Biosciences Inc. | 6.85 | -1.01% | $734.49M | vs DNA |
| GLUEMonte Rosa Therapeutics Inc. | 10.17 | +3.04% | $867.64M | vs DNA |
| ODTXOdyssey Therapeutics Inc. | 18.08 | -0.28% | $868.90M | vs DNA |
| PRMEPrime Medicine Inc. | 3.90 | +11.43% | $707.37M | vs DNA |
Indexes, lists and sector
Largest Health Care stocks
Ginkgo Bioworks stock FAQ
What is Ginkgo Bioworks's stock price today?
DNA last traded at $11.47 as of Oct 7, 4:00 PM EDT, down 7.57% on the day. Prices are delayed at least 15 minutes.
When is Ginkgo Bioworks's next earnings date?
Ginkgo Bioworks is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.58.
What is the DNA 52-week high?
The 52-week high for DNA is $18.22 and the 52-week low is $5.37. The stock is currently 37.0% below its high.